SCHEMBL25560799

SCHEMBL25560799

COc1cc(CCO)c(C(=O)O)c(O)c1C/C=C(\C)CCC=C(C)C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.78
▸ PPARD Q03181 4/20 0.78
▸ PPARA Q07869 4/20 0.78
▸ DNMT1 P26358 1/20 0.78
▸ SIRT5 Q9NXA8 1/20 0.78
▸ CRHBP P24387 1/20 0.62
▸ CRHR2 Q13324 1/20 0.62
▸ SLC6A3 Q01959 1/20 0.60
▸ TRPM7 Q96QT4 1/20 0.60
▸ DAGLA Q9Y4D2 1/20 0.60
▸ CNR2 P34972 1/20 0.59
▸ APP P05067 4/20 0.55
▸ BACE1 P56817 2/20 0.55
▸ PTPN1 P18031 1/20 0.55
▸ MAOB P27338 1/20 0.52
▸ PTGES O14684 1/20 0.51
▸ ALOX5 P09917 1/20 0.51
▸ PTGS1 P23219 1/20 0.51
▸ PTGS2 P35354 1/20 0.51
▸ OPRD1 P41143 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25560675 0.92 PPARG (0.78) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL29349841 0.89 PPARG (0.82) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL10039862 0.89 PPARG (0.82) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL29389477 0.88 PPARG (1.00) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL10039861 0.88 PPARG (1.00) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL12180036 0.84 APP (0.75) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL28334490 0.83 PPARG (0.75) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL28334500 0.81 PPARG (0.66) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL28334463 0.81 PPARG (0.66) PPARGPPARDPPARADNMT1SIRT5
SCHEMBL25560796 0.81 SLC6A3 (0.82) PPARGPPARDPPARADNMT1SIRT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165807-A1 COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF CALIBRATED THERAPEUTICS, LLC 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165807-A1 COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF CNR2, CNR1, FAAH PPARG 9/4885PPARD 42/4885PPARA 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback